Zerlasiran (sodium)

Produktübersicht

• Artikelname: Zerlasiran (sodium)
• Artikelnummer: MCE-HY-147425A
• Hersteller Artikelnummer: HY-147425A
• Alternativnummer: MCE-HY-147425A-1MG,MCE-HY-147425A-10MG,MCE-HY-147425A-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: SLN360 (sodium)

Produktbeschreibung

Zerlasiran (SLN360) sodium is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran sodium targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran sodium can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels[1][2].

Produkteigenschaften

• Molekulargewicht: 14155.88 (free acid)
• Reinheit: 95.52
• Formel: C443H556F12N144Na38O277P40S10
• Target-Kategorie: Apolipoprotein,Small Interfering RNA (siRNA)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Oligonucleotides